Literature DB >> 23402769

Nutrient transporters: the Achilles' heel of anabolism.

Alison N McCracken1, Aimee L Edinger.   

Abstract

Highly proliferative cells, including cancer cells, require a constant supply of molecular building blocks to support their growth. To acquire substrates such as glucose and amino acids from the extracellular space, dividing cells rely on transporter proteins in the plasma membrane. Numerous studies link transcriptional and post-translational control of nutrient transporter expression with proliferation, highlighting the importance of nutrient transporters in both physiologic and pathologic growth. Here we review recent work that spotlights the crucial role of nutrient transporters in cell growth and proliferation, discuss post-translational mechanisms for coordinating expression of different transporters, and consider the therapeutic potential of targeting these proteins in cancer and other diseases characterized by inappropriate cell division.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23402769      PMCID: PMC3617053          DOI: 10.1016/j.tem.2013.01.002

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  91 in total

1.  Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression.

Authors:  Qian Wang; Charles G Bailey; Cynthia Ng; Jessamy Tiffen; Annora Thoeng; Vineet Minhas; Melanie L Lehman; Stephen C Hendy; Grant Buchanan; Colleen C Nelson; John E J Rasko; Jeff Holst
Journal:  Cancer Res       Date:  2011-10-17       Impact factor: 12.701

Review 2.  Yeast sphingolipids: recent developments in understanding biosynthesis, regulation, and function.

Authors:  L Ashley Cowart; Lina M Obeid
Journal:  Biochim Biophys Acta       Date:  2006-08-10

3.  Glucose transporter polymorphisms are associated with clear-cell renal carcinoma.

Authors:  Tobias Page; Andrea D Hodgkinson; Martin Ollerenshaw; John C Hammonds; Andrew G Demaine
Journal:  Cancer Genet Cytogenet       Date:  2005-12

4.  Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy.

Authors:  Samuel K McBrayer; Javelin C Cheng; Seema Singhal; Nancy L Krett; Steven T Rosen; Mala Shanmugam
Journal:  Blood       Date:  2012-03-27       Impact factor: 22.113

Review 5.  Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.

Authors:  Vadivel Ganapathy; Muthusamy Thangaraju; Puttur D Prasad
Journal:  Pharmacol Ther       Date:  2008-11-01       Impact factor: 12.310

Review 6.  Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family.

Authors:  Bryan Mackenzie; Jeffrey D Erickson
Journal:  Pflugers Arch       Date:  2003-07-04       Impact factor: 3.657

7.  CD98hc facilitates B cell proliferation and adaptive humoral immunity.

Authors:  Joseph Cantor; Cecille D Browne; Raphael Ruppert; Chloé C Féral; Reinhard Fässler; Robert C Rickert; Mark H Ginsberg
Journal:  Nat Immunol       Date:  2009-03-08       Impact factor: 25.606

8.  HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5.

Authors:  Ainara Elorza; Inés Soro-Arnáiz; Florinda Meléndez-Rodríguez; Victoria Rodríguez-Vaello; Glenn Marsboom; Guillermo de Cárcer; Bárbara Acosta-Iborra; Lucas Albacete-Albacete; Angel Ordóñez; Leticia Serrano-Oviedo; Jose Miguel Giménez-Bachs; Alicia Vara-Vega; Antonio Salinas; Ricardo Sánchez-Prieto; Rafael Martín del Río; Francisco Sánchez-Madrid; Marcos Malumbres; Manuel O Landázuri; Julián Aragonés
Journal:  Mol Cell       Date:  2012-10-25       Impact factor: 17.970

9.  In vitro and in vivo study of phloretin-induced apoptosis in human liver cancer cells involving inhibition of type II glucose transporter.

Authors:  Chih-Hsiung Wu; Yuan-Soon Ho; Chia-Yi Tsai; Ying-Jan Wang; How Tseng; Po-Li Wei; Chia-Hwa Lee; Ren-Shyan Liu; Shyr-Yi Lin
Journal:  Int J Cancer       Date:  2009-05-01       Impact factor: 7.396

Review 10.  Targeting glucose metabolism for cancer therapy.

Authors:  Robert B Hamanaka; Navdeep S Chandel
Journal:  J Exp Med       Date:  2012-02-13       Impact factor: 14.307

View more
  51 in total

1.  CD98hc (SLC3A2) loss protects against ras-driven tumorigenesis by modulating integrin-mediated mechanotransduction.

Authors:  Soline Estrach; Sin-Ae Lee; Etienne Boulter; Sabrina Pisano; Aurélia Errante; Floriane S Tissot; Laurence Cailleteau; Catherine Pons; Mark H Ginsberg; Chloé C Féral
Journal:  Cancer Res       Date:  2014-09-29       Impact factor: 12.701

2.  Monitoring Cell-surface N-Glycoproteome Dynamics by Quantitative Proteomics Reveals Mechanistic Insights into Macrophage Differentiation.

Authors:  Mathias Kalxdorf; Stephan Gade; H Christian Eberl; Marcus Bantscheff
Journal:  Mol Cell Proteomics       Date:  2017-03-23       Impact factor: 5.911

Review 3.  Hypoxia and cellular metabolism in tumour pathophysiology.

Authors:  Scott K Parks; Yann Cormerais; Jacques Pouysségur
Journal:  J Physiol       Date:  2017-02-19       Impact factor: 5.182

4.  Affinity and path of binding xylopyranose unto E. coli xylose permease.

Authors:  Thierry O Wambo; Liao Y Chen; Clyde Phelix; George Perry
Journal:  Biochem Biophys Res Commun       Date:  2017-10-12       Impact factor: 3.575

5.  Interleukin-18 up-regulates amino acid transporters and facilitates amino acid-induced mTORC1 activation in natural killer cells.

Authors:  Saeedah Musaed Almutairi; Alaa Kassim Ali; William He; Doo-Seok Yang; Peyman Ghorbani; Lisheng Wang; Morgan D Fullerton; Seung-Hwan Lee
Journal:  J Biol Chem       Date:  2019-01-29       Impact factor: 5.157

6.  Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways.

Authors:  Seong M Kim; Saurabh G Roy; Bin Chen; Tiffany M Nguyen; Ryan J McMonigle; Alison N McCracken; Yanling Zhang; Satoshi Kofuji; Jue Hou; Elizabeth Selwan; Brendan T Finicle; Tricia T Nguyen; Archna Ravi; Manuel U Ramirez; Tim Wiher; Garret G Guenther; Mari Kono; Atsuo T Sasaki; Lois S Weisman; Eric O Potma; Bruce J Tromberg; Robert A Edwards; Stephen Hanessian; Aimee L Edinger
Journal:  J Clin Invest       Date:  2016-09-26       Impact factor: 14.808

7.  The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function.

Authors:  Andrew N Macintyre; Valerie A Gerriets; Amanda G Nichols; Ryan D Michalek; Michael C Rudolph; Divino Deoliveira; Steven M Anderson; E Dale Abel; Benny J Chen; Laura P Hale; Jeffrey C Rathmell
Journal:  Cell Metab       Date:  2014-06-12       Impact factor: 27.287

8.  Complementary α-arrestin-ubiquitin ligase complexes control nutrient transporter endocytosis in response to amino acids.

Authors:  Vasyl Ivashov; Johannes Zimmer; Sinead Schwabl; Jennifer Kahlhofer; Sabine Weys; Ronald Gstir; Thomas Jakschitz; Leopold Kremser; Günther K Bonn; Herbert Lindner; Lukas A Huber; Sebastien Leon; Oliver Schmidt; David Teis
Journal:  Elife       Date:  2020-08-03       Impact factor: 8.140

9.  Exploiting the co-reliance of tumours upon transport of amino acids and lactate: Gln and Tyr conjugates of MCT1 inhibitors.

Authors:  Reji N Nair; Jitendra K Mishra; Fangzheng Li; Mariola Tortosa; Chunying Yang; Joanne R Doherty; Michael Cameron; John L Cleveland; William R Roush; Thomas D Bannister
Journal:  Medchemcomm       Date:  2016-02-23       Impact factor: 3.597

Review 10.  Attacking the supply wagons to starve cancer cells to death.

Authors:  Elizabeth M Selwan; Brendan T Finicle; Seong M Kim; Aimee L Edinger
Journal:  FEBS Lett       Date:  2016-03-22       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.